Tag | Content |
---|
EnhancerAtlas ID | HS165-02442 |
Organism | Homo sapiens |
Tissue/cell | Ramos |
Coordinate | chr11:57192060-57193010 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
Tcf12 | MA0521.1 | chr11:57192872-57192883 | AACAGCTGCTG | + | 6.32 | ZNF263 | MA0528.1 | chr11:57192583-57192604 | TGAGGAGGATGAGGATGAAGC | + | 6.08 | ZNF263 | MA0528.1 | chr11:57192132-57192153 | AAAGGAAGGGGAGGAAAGGGG | + | 6.25 |
|
| Number of super-enhancer constituents: 5 | ID | Coordinate | Tissue/cell |
SE_09866 | chr11:57186394-57195934 | CD14 | SE_40224 | chr11:57191266-57195506 | K562 | SE_56335 | chr11:57191056-57196539 | u87 | SE_58962 | chr11:57170849-57195646 | Ly3 | SE_67811 | chr11:57191056-57196539 | u87 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
Enhancer Sequence | TTTGGGGGTC TTGTAAGGCA TGGAGTAAAA AAAAAAAAGC AATATCCTAA GGCTGGAGAA 60 GAGGGAGGGG ACAAAGGAAG GGGAGGAAAG GGGAGGTAGC AGGGAGCCAA GGACCAAGAA 120 GGACTGAGGT ACAGTCATTC TGCATCCAAA GGCTTAAATT GTAAGGGACT GGCTTTACTC 180 TGGCTGTTTC CGGAAAGGCA GGCCCAGCCA GCCCTCCCGT CTCTCTCTCT GACAGCCAAT 240 CTCACATGTG CCTCCCTGGG AGCACCTGCT CTGAGCTGTA TCAGCCCCCA GCAGGCCGCT 300 GATTACCACT GAGCCTGGCC ACAGAGCACG AGATTAGGAT GCAGCAACAC ACTGTGTGTG 360 AGATCACGTC CCGAACCTTC TGACTCATCT GCACAGGAAA CCCCCCCAGT CTCCCCTCCA 420 GTCAGAAGGG ACCTGAAATT CCACCAGTGG CAATACCAAA GAAACTTCCT ATTAGCTAAG 480 CCCCTAGGGA GTGATTGGCT GTTGGGGCGG GGAGGGGGGG CGGTGAGGAG GATGAGGATG 540 AAGCCTGGGC AACCTGGATG TGAGGCTGTG CAGGGGATGA GGACAAGGAT CCTTGGGGTG 600 AAGGAAGAGA AGAGCAATTT TAGGTTTTGC TAATTTTGTA ACCCTGGCTC CAAGCCAGCC 660 CTTACAGGAA GTCACCCTGG CCTCCGGCTC AATTCAGCAC GTGATAGGGA AGCCACATTT 720 ATGCAGAGCA GGGAACGAGG TAAGGAAATG GAAGTGGGGC TGTGGTGAAG TGGGCAAGTC 780 TAGAGAGAGT CCCGCTGCCT GGGGCTGTTC CTAACAGCTG CTGGGAGCGA GCTGCAGGTG 840 TGGTGCCTGG CAGGGTGGCC GGGCTGTCTG ACTCTGGATT TCACTCCAAG CTAGGCTGCT 900 GCCTGAAGGA TTCCTCTTAC CCACCTTTGC CTGGGCTGGC CTTTGGGACT 950
|